Access to high quality, safe, effective, and affordable generic medicines remains a significant public health priority. The role that the CRCG plays in fostering collaboration between FDA, industry, academia, and other key stakeholders through its education, training, research, and other activities directly helps the generic industry to address scientific challenges and accelerates the development of generic products, including complex generics. AAM is excited to continue its collaboration with CRCG to ensure more generic medicines are being developed and made accessible to patients and healthcare systems who need them.